Viperin is a radical SAM enzyme that possesses antiviral properties against a broad range of enveloped viruses. Here, we describe the activity of human viperin with two molecules of the mevalonate pathway, geranyl pyrophosphate, and farnesyl pyrophosphate, involved in cholesterol biosynthesis. We postulate that the radical modification of these two molecules by viperin might lead to defects in cholesterol synthesis, thereby affecting the composition of lipid rafts and subsequent enveloped virus budding.
Viperin (Virus Inhibitory Protein Endoplasmic Reticulum-associated, Interferon inducible) is an antiviral factor encoded by a type I interferon stimulated gene [1] . Viperin has been shown to inhibit replication of several viruses including Hepatitis C (HCV), West Nile, Dengue, Chikungunya, Influenza A, Sendai or Human Immunodeficiency viruses [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Human viperin is a 361-amino acid-long protein that belongs to the radical S-adenosyl-L-methionine (SAM) enzyme superfamily [14, 15] . It is composed of three distinct domains: a nonconserved N-terminal domain, containing an amphipathic helix and a leucine-zipper motif, which mediates its targeting to the endoplasmic reticulum [16] , lipid droplets [17] , and mitochondria [18] ; a conserved C-terminal domain proposed to be involved in substrate recognition and protein-protein interactions [4, 19, 20] and the conserved central domain that corresponds to the radical SAM domain and consists of a (ba) 6 three-quarter barrel. Radical SAM enzymes use a reduced [Fe 4 S 4 ] + cluster to cleave SAM and produce methionine and a highly reactive 5 0 -deoxyadenosyl radical (5 0 dA Á ) species, which subsequently abstracts, in most cases, a hydrogen atom from its substrate, forming a substrate radical species capable of undergoing further chemical reactions ( Fig. 1 ) [21, 22] . Viperin's viral restriction mode of action is still unknown but some evidence indicates it is implicated in the control of lipid production during viral infection by blocking key steps of lipid biosynthesis. Thus, the protein has been proposed to: (a) block the formation of the Hepatitis C virus replication complex by interfering with the virus association on lipid droplets, which is the site of replication [20] ; (b) be hijacked by Human Cytomegalovirus in order to both decrease ATP production and increase lipid biosynthesis to facilitate viral escape from infected cells [18, 23] and (c) inhibit the Influenza A virus budding and release steps by decreasing membrane fluidity and disrupting lipid raft microdomains in the plasma membrane [7] , a mechanism that has also been described for HIV-1 [24] . That study suggested that the lipid raft disruption might be caused by the inhibition by viperin of farnesyl pyrophosphate synthase (FPPS), a key enzyme for the production of isoprenoid-derived molecules such as cholesterol ( Fig. 2 ) [7] . However, studies by others [25] and us have not detected any interactions, either in vitro or in cellulo between these two proteins. Furthermore, recent biochemical studies have not found any modification of the viperin activity in the presence of FPPS. Taken together, these observations suggest that FPPS is not a substrate of viperin [25] . The recently published structure of the mouse viperin suggests instead that a nucleotide triphosphate could be its substrate [26] . Also, UDP-glucose was shown to be an in vitro substrate for a fungal viperin [27] . Here, we report the identification of geranyl pyrophosphate (GPP) and farnesyl pyrophosphate (FPP), two terpene intermediates in the mevalonate pathway (Fig. 2) , as substrates of human viperin. We also show that 5 0 dA Á can abstract a hydrogen atom from both GPP and FPP. We further hypothesize that the derived molecules will inhibit the subsequent isoprenoid enzymatic cascade, preventing cholesterol formation and virus budding from infected cells.
Materials and methods

Protein expression, reconstitution, and purification
In this study, we have cloned five different viperin constructs (Appendix S1). For the human, falcon and chinchilla constructs, 2 L of LB medium was inoculated with 20 mL of precultured Escherichia coli BL21-DE3-CodonPlus (RIL) cells containing the construct of interest until an O.D. of approximately 0.8. Then, the protein expression was triggered by the addition of arabinose to a final concentration of 0.2% and incubated for 18 h at 20°C. Cells were harvested by centrifugation and stored at À20°C for further use. The mouse construct was expressed by the addition of 0.2 mM IPTG as described in reference [26] . Cells were lysed in 300 mM NaCl, 50 mM Tris, pH 7.4 and all further steps were performed under anaerobic conditions using a glove box (Jacomex Ò ) with oxygen concentrations of about 2-5 p.p.m. The reconstitution of the iron-sulfur cluster was performed by the addition of 5 mM DTT, 1 mM FeCl 3 and 1 mM Na 2 S to the crude extract under mild stirring for 2 h at 18°C. The lysate was then clarified by centrifugation and applied to either a glutathione sepharose column, an amylose column or a His-Trap column (GE Healthcare TM ) depending on the construct (see Appendix S1). TEV cleavage was performed in the chosen column overnight and the cleaved protein was eluted using running buffer. After this step, we measured the iron-sulfur cluster content of the protein (Appendix S1). Depending on this value, a second reconstitution was performed by the addition of 1 mM FeCl 3 and 1 mM Na 2 S during a 2-h period. The proteins were finally filtrated and applied to a gel filtration Superdex 75 10/300 Increase column (GE Healthcare TM ) in 100 mM NaCl, 50 mM Tris, pH 8.5. The last purification step of the mouse viperin involved changing the buffer solution used in the HiTrap Desalting column (GE Healthcare TM ) to a 25 mM NaCl, 5 mM HEPES buffer, pH 7.1 as described [26] .
The human FPPS gene, a gift from Pr. Udo Oppermann (Structural Genomics Consortium, University of Oxford), was cloned in the p11 vector as a 6xHis-Tag recombinant protein. The FPPS protein was expressed in E. coli BL21-DE3-CodonPlus (RIL) strain for 2 h at 37°C by the addition of IPTG. It was first purified by a nickel affinity 
Results
Biochemical and biophysical characterization of human viperin
Different human viperin clones, lacking the N-terminal amphipathic helix to increase their solubility purpose (Appendix S1), were expressed in E. coli as GST-or MBP-fusion proteins and anaerobically reconstituted . Carbon atom numbering is indicated for GPP and FPP. We propose that the modification of GPP or FPP is initiated by abstraction of a hydrogen atom from CH 3 end, C8 or C9 in GPP, and C12, C13, or C14 in FPP. Modification on this part of the molecule could be tolerated by the FPPS or SQS enzymes but probably would interfere with the activity of the following enzymes, SQLE or LSS. In any case, the formation of cholesterol would be impaired.
by an addition of both FeCl 3 and Na 2 S to the crude extract (Materials and methods). Each construct was then purified by an affinity chromatography step followed by a gel filtration step (Materials and methods and Fig. S1A ). The ratio of the concentrations calculated using the absorbance at 280 and 410 nm gives the iron content (Appendix S1 and Fig. S1B ). For each construct, the [Fe 4 S 4 ] cluster reconstitution was partial after the first reconstitution step showing about 0.6 cluster per protein but was complete after the second reconstitution step (Fig. S1B ). Correct protein folding was verified by circular dichroism (CD) and the measured CD spectra were in agreement with previously reported data (Fig. S1C ) [15, 28] . Finally, the thermostability measurements of the different proteins show a melting temperature of approximately 52°C after reconstitution (Fig. S1D ).
We verified that our viperin constructs were able to cleave SAM in the absence of substrate by measuring 5 0 dA production as already described for human viperin [14] (Fig. 3, Figs S2-S5 ). In this case, 5 0 dA Á abstracts a hydrogen atom from a component in the solution carrying out a futile cycle (Fig. 1) . However, our HPLC analysis of 5 0 dA production showed that without the addition of any substrate, human viperin HVip45-361, which lacks its N-terminal amphipathic helix, has low activity under our experimental conditions, with 7.6 lM of 5 0 dA produced for 30 lM of protein in 120 min, corresponding to 0.25 turnovers (Fig. 3) . Conversely, it was to be expected that generally the addition of substrate should result in a significant increase in SAM cleaving activity.
Terpenoid molecules involved in the cholesterol synthesis pathway are substrates of human viperin
We next looked for substrates of viperin by monitoring 5 0 dA production. We first tested the effect of purified FPPS and found no increase in 5 0 dA production (Fig. S2B) , suggesting that this enzyme is not a substrate of human viperin. This result was further confirmed by native gel electrophoresis, which showed no interaction between these two proteins (Fig. S2A ) This result is in agreement with data recently reported by Makins et al. [25] .
We next examined the activity of human viperin in the presence of different small molecules, including terpenoid intermediates in the mevalonate pathway. The latter, also called the isoprenoid pathway is used by eukaryotes to produce IPP and DMAPP, two metabolites involved in processes such as the synthesis of terpenoids, steroids and protein prenylation (Fig. 2) [29] .
FPPS uses the IPP and DMAPP precursors to catalyze two reactions leading to the formation of GPP and FPP (Fig. 2) . Interestingly, addition of either GPP or FPP to our reaction assay increased the SAM-cleavage activity of viperin by a factor of 8 and 5, respectively (Fig. 3) . Conversely, IPP, DMAPP, and GGPP did not show any increase in 5 0 dA production (Fig. 3) . The presence of a diphosphate moiety appears to be crucial for substrate binding because farnesol and geraniol, which do not have the diphosphate moiety, do not induce such increase in 5 0 dA production (Fig. 3) . We finally tested UDP-glucose as a substrate for human viperin because it was recently described as a substrate for the fungal Thielavia terrestris viperin [27] . In their study, Ebrahimi et al. [27] reported a decrease in the 5 0 dA production in the presence of UDP-glucose, in agreement with their detection of a new product, which would correspond to a 5 0 dA adduct of UDP-glucose. With human viperin HVip45-361, we observed neither a decrease, nor an enhancement in 5 0 dA production in the presence of UDP-glucose (Fig. 3) , suggesting that UDP-glucose is not a substrate for this protein. Furthermore, and in contrast to what was reported for the fungal viperin, we did not detect any product that could correspond to a UDPglucose-derived 5 0 dA adduct. In order to further understand the role of GPP and FPP in the stimulation of SAM cleavage by human viperin, we performed a deuterium-labeling experiment to investigate whether these two molecules were directly involved in the radical SAM activity of the protein. We buffer-exchanged HVip45-361 using a solution containing D 2 O instead of H 2 O and performed the same SAM-cleavage experiment.
In the absence of substrate, we observed that the 5 0 dA resulting from the futile cycles exhibits a m/ z = 252.7, in agreement with incorporation of one deuterium atom from a solvent exchangeable position. Using IPP or UDP-glucose, which we previously showed do not enhance 5 0 dA production, the same deuterium incorporation is observed. Conversely, when either hydrogenated GPP or FPP is added, in addition to an enhancement in its production, 5 0 dA exhibits a m/z = 251.7, supporting incorporation of a nonexchangeable hydrogen atom likely coming from the terpenoid chains of either GPP or FPP (Fig. 4) . This experiment strongly suggests that both GPP and FPP are substrates of human viperin.
The human viperin-binding pocket can accommodate both GPP and FPP substrates
In order to investigate how GPP and FPP could bind to viperin, we docked these two molecules using the mouse viperin X-ray structure as the target [26] (Appendix S1 and Fig. 5) . Analysis of this structure shows that a patch of basic residues is located at the bottom of the ¾ b-barrel. This patch composed of conserved lysine and arginine residues, which in the mouse viperin correspond to K120 (K119 in human), R245 (R244), K220 (K219), and K247 (K246) is strictly conserved in all known viperin sequences and has been proposed to be involved in substrate binding [26] . Fenwick et al. [26] also outlined the high similarity between viperin and MoaA, another radical SAM enzyme that uses guanosine triphosphate as substrate 0 dA production was assayed using the human viperin construct HVip45-361 (30 lM) by adding SAM (1 mM), sodium dithionite (1 mM) and various molecules (300 lM) to the proteincontaining reaction mixture, which was incubated for 120 min at 20°C. Among the isoprenoid tested molecules, GPP and FPP drastically increased the basal activity of human viperin by a factor of about 8 and 5, respectively. Farnesol and geraniol, which lack the pyrophosphate group, did not show the same level of activity. This fact supports the hypothesis that phosphate groups are important for viperin's activity [26] . In addition, we tested UDP-glucose, previously suggested to be a substrate for the fungal Thielavia terrestris viperin [27] and found that it did not increase of SAM cleavage by human viperin. and contains a similar basic patch. Consequently, they concluded that viperin substrates should contain triphosphate moieties [26] . In all the docking poses, we found that this cationic patch of basic residues stabilizes the phosphate group of both GPP and FPP, suggesting that these substrates should bind with the phosphate groups placed at the bottom of the b-barrel. Figure 5 shows the poses we found where a carbon atom lies less than 5 A away from the C5 0 atom of the 5 0 dA; it suggests that the modification of GPP or FPP could occur at the aliphatic end of the molecule, in agreement with our deuterium-labeling experiments. Indeed, the aliphatic part of GPP and FPP is composed of several methyl groups from which a hydrogen atom can be abstracted by 5 0 dA Á . Conversely, our data would exclude addition of 5 0 dA Á to a double bond of the isoprenoid moieties. We also found that the addition of Mg 2+ cancels 5 0 dA production enhancement in the presence of either GPP or FPP (Fig. S3 ). This observation is in agreement with what was observed in MoaA, for which Mg 2+ decreases the enzymatic activity by about 40% [30] . We thus propose a similar effect in viperin with Mg 2+ preventing GPP or FPP binding through competitive interaction of their pyrophosphate moiety with the cationic patch [30] . This result also suggests direct interactions between the protein and the diphosphate moiety. We noticed as well that the active site cavity shows a large and relatively polar environment with a low affinity for lipid chains (Fig. 5) , suggesting that viperin has broad substrate selectivity. This is supported by the fact that viperin acts not only on many different types of viruses, but also at different stages in their reproductive cycles.
Both the N-and C-terminal regions of viperin are important for substrate recognition
We further probed the role of the protein matrix in substrate recognition through the production of several variants. We first wondered whether the C-terminal domain of human viperin was important for substrate recognition. We tested 5 0 dA production by HVip60-341, which lacks 20 amino acids at its C-terminus. We no longer observed any enhancement when using GPP and, conversely, we noticed a drastic diminution when using FPP (Fig. S4) . Removing the last 67 residues at the C terminus (HVip60-294) leads to a nonsoluble protein. Consequently, we propose that the C-terminal domain of viperin is important for substrate recognition and plays a role in substrate selectivity possibly by stabilizing the active site cavity.
We also tested the SAM-cleavage activity of viperins from different organisms including the mouse (MVip45-362), chinchilla (CVip58-358), and falcon (FVip1-305) viperins. In the absence of any substrate, human viperin HVip60-361 performs 0.23 turnover in 2 h. The mouse, chinchilla, and falcon viperins performed 0.3, 0.007, and 0.02 turnovers, respectively (Fig. S5) . In striking contrast to human viperin, which exhibits a significantly higher increase in 5 0 dA production in the presence of GPP relative to FPP, the three other proteins produce more 5 0 dA in the presence of FPP (Fig. S6) . Furthermore, the mouse and falcon viperin do not exhibit any enhancement in 5 0 dA production in the presence of GPP. These differences are not due to residues at the active site pocket because the amino acid sequence alignment of these four viperins shows they are fully conserved (Fig. S6) . The only significant difference lies in the N-terminal region (residues 44-74 and residues 45-75 in human and mouse viperins, respectively), which are not present in the crystallized mouse protein [26] . Consequently, we propose that the N-terminal domain also plays a role in substrate recognition and binding.
Discussion
To date, eight radical SAM enzymes have been identified in human; four are implicated in tRNA modifications (CDK5RAP1, CDKAL1, TYW1, ELP3) [31, 32] , two are involved in cofactor biosynthesis (MOCS1/ MoaA, LIAS/LipA) [33] , and the last two (RSAD1 and viperin) [34] do not have a known enzymatic activity. However, from a human health standpoint, it is essential to understand the mechanism of action of viperin against HIV, West Nile virus, Dengue virus, Tick-Borne Encephalitis virus, Hepatitis C virus, and Human Cytomegalovirus [2] [3] [4] 18] . This understanding should begin by the identification of its substrate(s).
In this work, we have identified two potential substrates of human viperin, namely GPP and FPP. Both are produced by a two-step reaction catalyzed by FPPS using DMAPP and IPP, the building blocks of the mevalonate pathway, as substrates (Fig. 2) . GPP and FPP drastically increase the radical-generating SAM-cleavage reaction of human viperin and we have shown, using LC-MS, that the 5 0 dA Á radical most probably abstracts a nonexchangeable hydrogen atom from these molecules. In addition, we conclude from our molecular docking experiments based on the mouse crystal structure [26] that viperin has a relatively large and nonhydrophobic active site cavity, which is not specific for lipid chains (Fig. 5) . This suggests that viperin may have low substrate selectivity rendering it capable of responding to different stresses. Indeed, it has already been shown that viperin is implicated in the restriction of different viruses through different pathways [7, 17, 18, 20] ; this substrate promiscuity could explain the action of viperin at different levels of virus inhibition. However, we agree with Fenwick et al. [26] that the substrates should contain phosphate moieties because a basic patch at the active site appears to be optimized to recognize di-or triphosphates. Radical SAM proteins exhibit a similar tridimensional fold composed of a full (ba) 8 -barrel or a partial (ba) 6 three-quarter barrel core often surrounded by a variable and specific N-and C-terminal extra domains completing the active site [35] . Based on our mutagenesis experiments (Figs S4 and S5 ) and on the crystal structure of mouse viperin [26] , we hypothesize that both N-and C-terminal domains are located at the same region and may act synergistically to help substrate access to the catalytic pocket. The top of the barrel is composed of the C terminus end of the core strands with the catalytic motif (CX 3 CX 2 C) located after the b1 strand. The [Fe 4 S 4 ] cluster and the cofactor are also located at the top of the cavity (Fig. 5) . The bottom of the barrel is composed of the N terminus start of the core strands and is lined up with residues conserved among homologous viperin sequences (Fig. S6) [26] . As shown by our molecular docking experiments based on the crystal structure of the mouse viperin [26] and its comparison to the MoaA structure in complex with GTP [30] , we propose that the GPP and FPP bind the radical SAM domain of viperin with their terpenoid chain facing the C5 0 atom of SAM at the top of the barrel. Consequently, we propose that viperin performs its hydrogen-atom abstraction from a CH 3 group (C8 or C9 in GPP and C12, C13 or C14 in FPP). Conversely, the pyrophosphate end would bind to the basic patch at the bottom of the b-barrel. Although we have not yet characterized the reaction of viperin with GPP or FPP, we anticipate that it could involve an oxidation or an isomerization of the substrate's lipid chain; such reactions are often catalyzed by radical SAM enzymes [36] . We will attempt the characterization of the enzyme products next.
Our proposed mechanism is radically different from the one described for the fungal viperin [27] , that involves an addition of the 5 0 dA Á radical and a hydrogen atom to either a C=C or C=O bond of UDP-glucose. Indeed, we did not see either an increase or a decrease in 5 0 dA production in human or mouse viperin in the presence of UDP-glucose (Fig. 3) . Furthermore, we did not observe any adduct at m/z = 818.16 corresponding to the modified product previously described [27] . We also scanned a potential adduct of 5 0 dA resulting from its reaction with either GPP or FPP without success, confirming that the enzymatic mechanism of human viperin is different from the fungal one. The different substrates and enzymatic reactions of these two enzymes could be explained by their low sequence identity,~47% compared to~80% between human and mouse, chinchilla or falcon sequences (Fig. S6) .
Interestingly, FPP is also involved in protein prenylation through the formation of GGPP (Fig. 2) , indicating that its modification by viperin could also lead to the inhibition of the protein prenylation cascade. It is noteworthy that lovastatin, an inhibitor of the mevalonate pathway, inhibits the localization of the Hepatitis C virus (HCV) replication complex on the endoplasmic reticulum membranes and that this process is reversed by the addition of geranylgeraniol [37] . Ye et al. stated that one or more geranylgeranylated cellular proteins are required for the localization and assembly of the HCV RNA replication complex and that lovastatin blocks virus replication by depleting endogenous GGPP, thereby preventing geranylgeranylation of the critical proteins. It is then possible that a viperin-driven modification of FPP will, in turn, lead to GGPP modification and to HCV replication complex disruption as observed on lipid droplets [17, 19, 20] . Also, a recent study shows that the overexpression of human viperin in E. coli leads to modifications in cell morphology [38] . Indeed, there is an alternative pathway in bacteria and the plastids of plants called the MEP (2-Methyl-D-erythritol-4-phosphate) pathway leading to IPP and DMAPP formation [29, 39, 40] . Bacteria use these two molecules to produce GPP, FPP, and all downstream molecules including cholesterol. That study thus supports the hypothesis that viperin's activity might affect the lipid composition of cells, including bacterial. Consequently with this idea, the viperin-driven disruption of lipid rafts observed in Influenza A and HIV virus budding has been shown to be linked to the disruption of the mevalonate pathway and to the diminution of cholesterol synthesis [7, 24] .
Further studies will be aimed at identifying the step in the mevalonate pathway where inhibition may occur, triggered by the viperin-modified GPP and FPP products. FPPS and the squalene synthase (SQS) are most probably not inhibited because they catalyze the addition of carbon chains at the pyrophosphate end and our study suggests that the chemical modification of GPP or FPP should occur at their aliphatic chains. In contrast, the next enzymes in the pathway, squalene monooxygenase (SQLE) and lanosterol synthase (LSS), could be inhibited as they react with the aliphatic ends of their substrates. Future in vitro and in vivo experiments should validate this hypothesis.
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